PSA, Free ELISA Kit

Immunoassay for prostate-specific antigen measurement in prostate cancer screening. Provides quantitative measurement for clinical decision-making.

Prostate-specific antigen assay for screening and monitoring of prostate cancer. Quantitative measurement of PSA in serum samples.

FIA-based quantitative test kit for PSA measurement in prostate health screening. Designed for point-of-care testing applications.

A lateral flow immunoassay test kit for detection of prostate-specific antigen levels. This test aids in prostate health screening and early detection of abnormalities.

Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.

Chemiluminescence immunoassay for total prostate-specific antigen measurement with analytical sensitivity of 0.005 ng/ml and linearity up to 100 ng/ml.

Immunofluorescence test kit for simultaneous detection of AFP, CEA, and total PSA biomarkers. Used for cancer screening and monitoring in clinical laboratories and point-of-care settings. Provides rapid quantitative results for liver, colorectal, and prostate cancer assessment.

A non-invasive, urine-sample-based diagnostic kit for prostate cancer detection and risk assessment. The kit utilizes PSA N-glycosylation analysis to detect asparagine-linked carbohydrates of PSA, providing comprehensive clinical insights into prostate cancer-related alterations. It employs recombinant antibody technology to ensure selectivity and cost-effectiveness, and is designed for simplicity, requiring no specialized or highly skilled operator personnel. The diagnostic method significantly reduces false-positive rates compared to conventional serum PSA tests.

Non-invasive urine-based diagnostic test that analyzes asparagine-linked carbohydrates of PSA to detect prostate cancer and assess disease aggressiveness. The assay provides comprehensive N-glycomic profiling in a single test, reducing false positives and unnecessary clinical interventions.

Quantitative measurement kit for Alpha-Fetoprotein in clinical diagnostics and oncology applications.

A diagnostic test kit for measuring elastase levels in seminal plasma using enzyme-linked immunosorbent assay (ELISA). It is used to evaluate seminal quality and male reproductive health.

Rapid screening assays for AFP, CEA, PSA, and other key oncology markers enabling accessible, early-stage risk stratification in community health screening and specialist oncology settings. Offers quantitative fluorescence and semi-quantitative formats with low sample volume requirements of 50–100 µL serum/plasma. Multi-marker combo panels are available.